IPO Trending
CBPLSME / BSEListed
Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited, established in 2003, is engaged in marketing lifesaving medicines in India across therapeutic areas such as cardiovascular care, cancer treatment, antibiotics, hormones, anesthesia, pediatrics, nephrology, antiviral, antifungal, and neurology. The company operates under its own brand with the support of an in-house sales team and distribution network that supplies healthcare centers and hospitals, while also dealing in specialty chemicals. In addition to finished formulations, it imports, supplies, and undertakes indenting of active pharmaceutical ingredients and intermediates, and holds FDA approval to manufacture formulations through contract manufacturers. Its storage facilities are located on a leased basis in Bhiwandi, Thane, Maharashtra, and the company also exports pharmaceutical products to international markets including DR Congo, Bolivia, and the Philippines.

₹51 - ₹51Open
Listed Price₹51.70
Listing Gain+1.37%

Subscription Status

0Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date31 Jan 2020
Close Date06 Feb 2020
Listing Date14 Feb 2020
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Chandra Bhagat Pharma IPO Subscription Demand

Live subscription status and bidding analysis for Chandra Bhagat Pharma (CBPL) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions